RxDoctor Payments Data

Jean Wilson, DO

Family Medicine · Hubbard, OHNPI 1700866266

Payments from drug & device makers

$2,400in general payments, 2019–2025

Across 148 payments — averaging $16.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$369
  • Novartis$253
  • Johnson & Johnson$228
  • Kiniksa Pharmaceuticals, Ltd.$180
  • Amarin Pharma, Inc.$179
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$108
  • plus $1K from 23 others

What the payments were for

  • Food & beverage$2,400100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,400 in reported general payments places this provider in the 75th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$55,957
Medicare patients
192
Services billed
614

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban54$62,925
JardianceEmpagliflozin37$36,935
JanuviaSitagliptin Phosphate45$34,576
OzempicSemaglutide19$33,246
XareltoRivaroxaban18$25,227
FarxigaDapagliflozin Propanediol19$15,059
Xtampza ErOxycodone Myristate13$12,010
Tresiba Flextouch U-100Insulin Degludec22$8,249
LinzessLinaclotide11$6,414
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog14$5,524
Levothyroxine Sodium440$3,847
Potassium Chloride141$3,221
Atorvastatin Calcium428$3,103
SynthroidLevothyroxine Sodium45$2,935
Pantoprazole Sodium249$2,699

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$96$64,35465 claims
Boehringer IngelheimJardiance$73$36,93537 claims
MerckJanuvia$60$34,57645 claims
Novo NordiskOzempic$106$33,24619 claims
Johnson & JohnsonXarelto$228$25,22718 claims
AstraZenecaFarxiga$79$15,05919 claims
AbbVieLinzess, Synthroid$46$9,34856 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$17$3,847440 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Hubbard

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →